Viking Long Fund Master Ltd.'s Net Worth
$0
Who is Viking Long Fund Master Ltd.?
Viking Long Fund Master Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Wayfair Inc., FIRST DATA CORP, Adaptive Biotechnologies Corp, Editas Medicine, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., Urovant Sciences Ltd., Axovant Sciences Ltd., and BridgeBio Pharma, Inc..
SEC CIK
Viking Long Fund Master Ltd.'s CIK is 0001621596
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 4
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.00M |
$55.65 | -$55,650,000.00 | 29.99M |
Dec 14
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Urovant Sciences Ltd. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +0.08% | 18.2K |
$8.32 | $151,380.99 | 22.86M |
Scheduled
|
Jun 17 - Jun 19
| ||
Form 4
| +0.10% | 22.01K |
$8.06 | $177,300.64 | 22.84M |
Scheduled
|
Jun 12 - Jun 14
| ||
Form 4
| +0.09% | 21.34K |
$8.31 | $177,247.38 | 22.82M |
Scheduled
|
Jun 7 - Jun 11
| ||
Form 4
| +0.09% | 21.12K |
$7.86 | $165,950.15 | 22.8M |
Scheduled
|
Jun 4 - Jun 6
| ||
Form 4
| +0.08% | 17.75K |
$7.83 | $138,946.36 | 22.78M |
Scheduled
|
May 30 - Jun 3
| ||
Form 4
| +0.06% | 14.48K |
$7.63 | $110,461.18 | 22.76M |
Scheduled
|
May 24 - May 29
| ||
Form 4
| +0.09% | 19.83K |
$8.22 | $162,918.35 | 22.75M |
Scheduled
|
May 21 - May 23
| ||
Form 4
| +0.07% | 21.61K |
$7.63 | $162,884.29 | 31.35M |
May 16 - May 20
| |||
Form 4
| +13.38% | 2.68M |
$14.00 | $37,499,994.00 | 22.7M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||